Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 290: C200-C207, 2006. First published August 24, 2005; doi:10.1152/ajpcell.00269.2005
0363-6143/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/C200    most recent
00269.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uezono, Y.
Right arrow Articles by Taniyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uezono, Y.
Right arrow Articles by Taniyama, K.

RECEPTORS AND SIGNAL TRANSDUCTION

Coupling of GABAB receptor GABAB2 subunit to G proteins: evidence from Xenopus oocyte and baby hamster kidney cell expression system

Yasuhito Uezono,1 Masato Kanaide,2 Muneshige Kaibara,1 Rachel Barzilai,3 Nathan Dascal,3 Koji Sumikawa,2 and Kohtaro Taniyama1

Departments of 1Pharmacology and 2Anesthesiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; and 3Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel

Submitted 8 June 2005 ; accepted in final form 17 August 2005


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Coupling of functional GABAB receptors (GABABR) to G proteins was investigated with an expression system of baby hamster kidney (BHK) cells and Xenopus oocytes. Fluorescence resonance energy transfer (FRET) analysis of BHK cells coexpressing GABAB1a receptor (GB1aR) fused to Cerulean, a brighter variant of cyan fluorescent protein, and GABAB2 receptor (GB2R) fused to Venus, a brighter variant of yellow fluorescent protein, revealed that GB1aR-Cerulean and GB2R-Venus form a heterodimer. The GABABR agonists baclofen and 3-aminopropylphosphonic acid (3-APPA) elicited inward-rectifying K+ currents in a concentration-dependent manner in oocytes expressing GB1aR and GB2R, or GB1aR-Cerulean and GB2R-Venus, together with G protein-activated inward-rectifying K+ channels (GIRKs), but not in oocytes expressing GB1aR alone or GB2R alone together with GIRKs. Oocytes coexpressing GB1aR + G{alpha}i2-fused GB2R (GB2R-G{alpha}i2) caused faster K+ currents in response to baclofen. Furthermore, oocytes coexpressing GB1aR + GB2R fused to G{alpha}qi5 (a chimeric G{alpha}q protein that activates PLC pathways) caused PLC-mediated Ca2+-activated Cl currents in response to baclofen. In contrast, these responses to baclofen were not observed in oocytes coexpressing GB1aR-G{alpha}i2 or GB1aR-G{alpha}qi5 together with GB2R. BHK cells and Xenopus oocytes coexpressing GB1aR-Cerulean + a triplet tandem of GB2R-Venus-G{alpha}qi5 caused FRET and Ca2+-activated Cl currents, respectively, with a similar potency in BHK cells coexpressing GB1aR-Cerulean + GB2R-Venus and in oocytes coexpressing GB1aR + GB2R-G{alpha}qi5. Our results indicate that functional GABABR forms a heterodimer composed of GB1R and GB2R and that the signal transducing G proteins are directly coupled to GB2R but not to GB1R.

fluorescence resonance energy transfer


GABAB RECEPTORS (GABABR) were the first G protein-coupled receptors discovered to form heterodimers consisting of two different receptor subunits, GABAB1 receptor (GB1R) and GABAB2 receptor (GB2R) (1, 3, 4). Neither receptor subunit can function when expressed in isolation (1, 4). GB1R is thought to be the site of agonist binding, whereas GB2R activates the G protein-coupled signaling system (10, 24). However, the mechanism through which GB2R activates G proteins in the complex of heterodimeric GABABR remains to be investigated. We investigated the GABABR subunit that directly couples to G proteins in the functional GABABR using an expression system of Xenopus oocytes and baby hamster kidney (BHK) cells. Heterodimerization of GABABR was determined in living BHK cells expressing GB1R fused to Cerulean (23) and GB2R fused to Venus (17) using fluorescence resonance energy transfer (FRET) analysis. Functional GABABR assays were conducted with the Xenopus oocyte expression system and electrophysiological assay of the G protein-activated inward-rectifying K+ channels (GIRKs) as previously described (27, 29). The Xenopus oocyte expression system has been used for analysis of the function of Gi/o-coupled receptors such as cannabinoid CB1 and CB2 receptors (12), muscarinic M2 receptor (M2R), and {delta}-opioid receptor (15, 27), as well as GABABR (27, 29).

To determine the subunit of GABABR (i.e., GB1R or GB2R) that is directly coupled to the G protein, we used Xenopus oocytes coexpressing one of each GABABR subunits fused to G{alpha}i2, a G protein that preferentially couples to GABABR-mediated signaling among Gi/o proteins in the central nervous system (CNS) (18, 19) and its counterpart. Cell signaling via the G protein fused to receptors is preferentially transmitted to the effectors rather than that via Gi/o proteins endogenously expressed in Xenopus oocytes (13, 20, 31). Accordingly, we determined the kinetics of GIRK activation on GABABR stimulation in oocytes that expressed both GB1R and GB2R fused to G{alpha}i2. Furthermore, coupling of the G protein to GABABR was also examined in oocytes expressing both GB1R and GB2R fused to a chimeric G{alpha}q protein, G{alpha}qi5, which contains the carboxy-terminal five amino acids of G{alpha}i. The chimeric G{alpha}qi proteins, including G{alpha}qi5, allow G{alpha}i protein-coupled receptors to couple to the PLC-mediated signal pathways (6, 9), and such G{alpha}qi-mediated signaling has been used for the output of GABABR-mediated signaling (7, 9, 10). FRET analysis was used in BHK cells coexpressing Cerulean- or Venus-fused GABABR to determine the heterodimerization of the receptors. Thus the objective of the present study was to characterize functionally and morphologically the GABABR subunit directly coupled to functional G proteins.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Drugs and chemicals. Baclofen, 3-aminopropylphosphonic acid (3-APPA), ACh, gentamicin, and sodium pyruvate were purchased from Sigma (St. Louis, MO). Other chemicals used in the study were of analytical grade and were obtained from Nacalai Tesuque (Kyoto, Japan).

Construction of cDNAs and preparation for cRNA. cDNAs for rat GIRK1 and mouse GIRK2 were provided by Dr. H. A. Lester (Caltech, Pasadena, CA). GABAB1a and GABAB1b receptors (GB1aR and GB1bR) and GB2R were from Dr. N. J. Fraser (Glaxo Wellcome, Stevenage, UK). Human M2R was from Dr. E. Peralta (Harvard University, Cambridge, MA). Rat G{alpha}i2 was from Dr. M. I. Simon (Caltech), and rat µ-opioid receptors were from N. Dascal. The chimeric G{alpha}qi5 was a kind gift from Dr. B. R. Conklin (University of California at San Francisco). Cerulean, a brighter variant of cyan fluorescent protein (23) was from Dr. D. W. Piston (Vanderbilt University, Nashville, TN), and Venus, a brighter variant of yellow fluorescent protein (17) was from Dr. T. Nagai (Riken, Wako, Japan). The GB1aR-G{alpha}i2, GB1bR-G{alpha}i2, GB2R-G{alpha}i2, and M2R-G{alpha}i2 tandem cDNAs were created by ligating the receptor cDNA sequences into the EcoRI site of the corresponding G{alpha}i2 cDNA. Each receptor-G{alpha}qi5 tandem was created by ligation of the receptor cDNA sequences into the NheI site of the corresponding G{alpha}qi5. GABABR-Cerulean, GABABR-Venus, and µ-opioid receptor-Venus were created by ligating the receptor cDNAs into the NotI or BamHI sites of the corresponding Venus or Cerulean sites. The GB2R-Venus-G{alpha}qi5 triplet tandem was created by ligating GB2R-Venus into the NheI site of corresponding G{alpha}qi5. All cDNAs for transfection in BHK cells were subcloned into pcDNA3.1 (Invitrogen). All cDNAs for the synthesis of cRNAs were subcloned into the pGEMHJ vector, which provides 5'- and 3'-untranslated regions of the Xenopus {beta}-globin RNA, ensuring a high level of protein expression in the oocytes (31). Each of the cRNAs was synthesized with a mCAP mRNA capping kit and with a T7 RNA polymerase in vitro transcription kit (Ambion, Austin, TX) from the respective linearized cDNAs.

Oocyte preparation and injection. Immature stages V and VI oocytes from Xenopus were enzymatically dissociated as previously described (27, 28). Isolated oocytes were incubated at 18°C in ND-96 medium (in mM: 96 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.4) containing 2.5 mM sodium pyruvate and 50 µg/ml gentamicin. For measurement of GIRK currents induced by baclofen or 3-APPA, cRNAs for GIRK1/2 (0.2 ng each) were injected into the oocytes with or without GB1aR, GB1bR, GB1aR-Cerulean, or GB1bR-Cerulean (5 ng each) and/or GB2R or GB2R-Venus (5 ng each). In some oocytes, cRNAs for GB1aR-G{alpha}qi5, GB2R-G{alpha}qi5, GB1aR-Cerulean-G{alpha}qi5, GB2R-Venus-G{alpha}qi5, M2R, or M2R-G{alpha}qi5 (5 ng each) were injected. The final injection volume was <50 nl in all cases. Oocytes were incubated in ND-96 and used 3–8 days after injection as reported previously (29).

Electrophysiological recordings. Electrophysiological recordings were performed using the two-electrode voltage-clamp method with a Geneclamp 500 amplifier (Axon Instruments, Foster City, CA) at room temperature. Oocytes were clamped at –60 mV and continuously superfused with ND-96 or 49 mM high-K+ (HK) solution (in mM: 48 NaCl, 49 KCl, 1 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.4) in a 0.25-ml chamber at a flow rate of 5 ml/min, and baclofen or 3-APPA (10–9 to 10–3 M) was added to the superfusion solution. Voltage recording microelectrodes were filled with 3 M KCl and had a tip resistance of 1.0–2.5 M{Omega}. Currents were continuously recorded and stored with MacLab (ADInstruments, Castle Hill, Australia) and a Macintosh computer, as described previously (27, 29). All test compounds applied to oocytes were dissolved in ND-96 or HK media.

Cell culture and transfection. BHK cells were grown in DMEM supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 µg/ml) at 37°C in a humidified atmosphere of 95% air-5% CO2. For transfection experiments, BHK cells were seeded at a density of 1 x 105 cells/35-mm glass-bottomed culture dish (Fluoro Physiotech) for 24 h. Transient transfection was then performed with Effectene transfection reagent (Qiagen, Tokyo, Japan) in 0.2 µg of each cDNA as described previously (25) and according to the protocol provided by the manufacturer. For titration assay of FRET efficiency, 0.2 µg of GB1aR-Cerulean and varying concentrations (0.05–0.5 µg) of GB2R-Venus cDNA were cotransfected. Cells were used in confocal microscopy and FRET analysis 16–20 h after transfection.

Confocal microscopy and FRET analysis. For the analysis of heterodimerization of GABABR using the FRET assay, GB1R and GB2R were fused through the carboxy terminus to Cerulean and Venus. BHK cells cultured in 35-mm glass-bottomed dishes were cotransfected with a combination of GB1aR-Cerulean or GB1bR-Cerulean + GB2R-Venus or GB1aR-Venus + GB2R-Cerulean. In some experiments, Cerulean, Venus, µ-opioid receptor-Venus, the triplet tandem of GB1aR-Cerulean-Gqi5, or GB2R-Venus-Gqi5 was also transfected. A x63 magnification, 1.25 numerical aperture oil-immersion objective was used with a pinhole for visualization. Both Cerulean and Venus were excited with a 458-nm laser, and images were obtained by placing the dish onto a stage in a Zeiss LSM510 META confocal microscope (Carl Zeiss, Jena, Germany).

Photobleaching and calculation of FRET efficiency. To confirm FRET between Cerulean and Venus, we monitored acceptor photobleaching analysis in living BHK cells coexpressing Cerulean-fused or Venus-fused GABABR. FRET was measured by imaging Cerulean before and after photobleaching Venus with the 100% intensity of a 514-nm argon laser for 2 min, a duration that efficiently bleached Venus with little effect on Cerulean. An increase of donor fluorescence (Cerulean) was interpreted as evidence of FRET from Cerulean to Venus. All experiments were analyzed in at least six cells with three independent regions of interest. As a control, we examined the FRET efficiency of the unbleached area of membrane in the same cell in at least three areas. In some cases we performed the photobleaching assay with fixed BHK cells. Cell fixation was performed as previously described (30).

FRET efficiency was calculated with emission spectra before and after acceptor photobleaching. In our study as well as others, this protocol had almost no effect on Cerulean in the absence of Venus (Ref. 16; see RESULTS). According to this procedure, if FRET is occurring, then photobleaching of the acceptor (Venus) should yield a significant increase in fluorescence of the donor (Cerulean). Increase of donor spectra due to desensitized acceptor was measured by taking the Cerulean emission (at 488 nm) from spectra before and after acceptor photobleaching. FRET efficiency was then calculated using the equation E = 1 – IDA/ID, where IDA is the peak of donor (Cerulean) emission in the presence of the acceptor and ID is the peak in the presence of the sensitized acceptor, as previously described (22). Before and after this bleaching, Cerulean images were collected to assess changes in donor fluorescence. Any increase in Cerulean fluorescence caused by bleaching of the Venus acceptor could be masked, at least in part, by bleaching of Cerulean related simply to the imaging process itself. To minimize the effect of photobleaching due to imaging, images were collected at 2.0% of the laser intensity, 50 times less than bleach intensity.

Statistical analysis. Data are expressed as means ± SE. Differences between two groups were examined for statistical significance with a paired t-test. GraphPad Prism software was used to analyze data for statistical significance and to analyze data and fit curves for baclofen and 3-APPA dose responses. For comparisons between multiple groups one-way ANOVA was used, followed by Scheffé's test. A P value of <0.05 denotes the presence of a statistically significant difference.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
FRET and acceptor photobleaching analysis of GABAB receptors expressed by BHK cells. Expression of GABABR composed of GB1R and GB2R on the cell surface was examined using FRET analysis in living BHK cells coexpressing GB1aR fused to Cerulean (GB1aR-Cerulean) and GB2R fused to Venus (GB2R-Venus). Confocal imaging in living cells showed that fluorescence from Cerulean and Venus was colocalized mostly on the cell membrane and in the cytoplasm, if any, of cells coexpressing GB1aR-Cerulean + GB2R-Venus (Fig. 1A, top). The same results were obtained with fixed BHK cells (data not shown). Photobleaching analysis demonstrated that Venus fluorescence was reduced by sustained 2-min application of a 514-nm wavelength at 100% intensity of the argon laser power to the indicated area (Fig. 1A, top). This 2-min application did not affect the fluorescence intensity of Cerulean and Venus in unbleached areas (data not shown). Also, this 2-min application had almost no effect on the fluorescence intensity of Cerulean on the cell surface in BHK cells expressing only GB2R-Cerulean (data not shown). With the use of acceptor photobleaching, Cerulean fluorescence (donor) was increased as the Venus fluorescence decreased (acceptor) (Fig. 1, A, bottom, and B). As shown in Fig. 1C, FRET efficiency was significantly higher in BHK cells coexpressing GB1aR-Cerulean + GB2R-Venus or GB1bR-Cerulean + GB2R-Venus than in the negative control (pairs of Cerulean + Venus and GB2R-Cerulean + µ-opioid receptor-Venus). A similar level of FRET efficiency was obtained in BHK cells coexpressing another pair of tandem GABABRs, GB1aR-Venus + GB2R-Cerulean (Fig. 1C).



View larger version (50K):
[in this window]
[in a new window]
 
Fig. 1. Confocal imaging and fluorescence resonance energy transfer (FRET) analysis of the dimerized GABAB1a receptor (GB1aR) and GABAB2 receptor (GB2R) in baby hamster kidney (BHK) cells expressing Cerulean-fused GB1aR (GB1aR-Cerulean) and Venus-fused GB2R (GB2R-Venus). A: visualization of the GB1aR-Cerulean and GB2R-Venus in cotransfected BHK cells (top) and fluorescence changes by acceptor photobleaching (2-min application of 514-nm wavelength; bottom). B: emission spectra from a BHK cell before and after Venus photobleaching as indicated in A. Note the increase of the Cerulean peak emission (488 nm) following the photobleaching of Venus (528 nm). Inset: mathematical equation used to calculate the FRET efficiency (E). IDA, peak of donor emission in presence of acceptor; ID, peak of donor emission in presence of sensitized acceptor. C: FRET efficiency of GB1aR-Cerulean + GB2R-Venus, GB1bR-Cerulean + GB2R-Venus, and GB1aR-Venus + GB2R-Cerulean pairs. The Venus + Cerulean and µ-opioid receptor-Venus + GB2R-Cerulean pairs were used as negative controls for interacting receptors. Each column represents mean ± SE of FRET efficiency in independent experiments using 6 cells with 3 regions of interests per BHK cell (n = 18). D: heterodimerization of GABABR assessment by FRET efficiency titration in living BHK cells. BHK cells were cotransfected with a constant amount (0.2 µg) of GB1aR-Cerulean and an increasing amount (0.05–0.5 µg) of GB2R-Venus. Acceptor photobleaching was performed within the membranes of the cells as indicated in A. The curve was fitted using a nonlinear regression equation assuming a single binding site (GraphPad Prism).

 
A recent report showed that, in addition to GABABR heterodimer, GB1R and GB2R can each associate as a stable homodimer (30). In our experimental system we also showed that GB2R-Cerulean + GB2R-Venus reached the cell surface and caused FRET with FRET efficiency similar to the combination of GB1aR-Cerulean + GB2R-Venus (GB2R-Cerulean/Venus; 0.30 ± 0.06, n = 18). GB1aR-Cerulean + GB1aR-Venus did not reach the cell surface, whereas they also formed a homodimer in the cytoplasm (as described in Ref. 30) and caused FRET with FRET efficiency similar to the combination of GB1aR-Cerulean + GB2R-Venus (GB1aR-Cerulean/Venus; 0.26 ± 0.09, n = 18).

To investigate the effects of the GB2R-Venus-to-GB1aR-Cerulean expression ratio on the FRET efficiency, we performed the FRET efficiency titration assay as previously described (30). As shown in Fig. 1D, FRET efficiency was saturable over the ratio (GB2R-Venus/GB1aR-Cerulean) of 1, which was in accordance with the results performed with titration of bioluminescence resonance energy transfer assay (30).

In living cells, small movement of cells or movement of organelles within cells might interfere the efficacy of FRET efficiency. Accordingly, we compared FRET efficiency between living and fixed BHK cells coexpressing GB1aR-Cerulean + GB2R-Venus. There was almost no difference between FRET efficiency in living and fixed cells (living BHK cells 0.34 ± 0.1, fixed 0.36 ± 0.08; n = 18 each), demonstrating that living cells did not interfere with the efficacy of photobleaching in our experimental system.

Response to GABABR agonists in Xenopus oocytes expressing functional GABABR. In oocytes coexpressing GB1aR or GB1bR together with GB2R and GIRK1/2, the GABABR agonists baclofen and 3-APPA (10–9 to 10–3 M) elicited inward-rectifying K+ currents in a concentration-dependent manner (Fig. 2 and Table 1). In contrast, both agonists failed to cause any response in oocytes individually coexpressing GB1aR, GB1bR, or GB2R together with GIRK1/2 (Fig. 2A; other data not shown). There were no differences in the time course and peak amplitude of GIRK currents between oocytes expressing GB1aR + GB2R and GB1bR + GB2R together with GIRK1/2 (Fig. 2B and Table 1). In oocytes coexpressing GB1aR-Cerulean + GB2R-Venus together with GIRK1/2, baclofen and 3-APPA also caused a concentration-dependent increase in K+ currents with EC50 values essentially similar to those measured in oocytes expressing nonfused GB1aR + GB2R together with GIRK1/2, demonstrating that addition of fluorescent proteins to the carboxy terminus of the GABABR subunit did not affect the ability to activate GIRK channels (Table 1).



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2. Baclofen- and 3-aminopropylphosphonic acid (3-APPA)-induced G protein-activated inward-rectifying K+ channel (GIRK) currents in Xenopus oocytes coexpressing GB1aR or GB1bR and GB2R together with GIRK1 and GIRK2 (GIRK1/2). A: representative trace of GIRK currents induced by baclofen in oocytes expressing GB1aR alone, GB2R alone, or both together with GIRK1/2 voltage-clamped at –60 mV. Baclofen at 10–4 M was applied as indicated by the horizontal bar for 60 s. HK, high-K+ solution. B: concentration-response curves of baclofen- or 3-APPA-induced GIRK currents in oocytes. Varying concentrations of baclofen or 3-APPA (10–9 to 10–3 M) were applied for 60 s in oocytes as indicated in A, and peak currents were measured. Each point represents mean ± SE of the peak GIRK currents expressed as net GIRK currents in 3–6 oocytes.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Baclofen- or 3-APPA-induced responses of Xenopus oocytes coexpressing GABAB receptor subunits fused to Cerulean or Venus

 
Acceleration of GIRK activation processes in Xenopus oocytes expressing GABABR fused to G{alpha}i2. Because there was no difference in GABABR-mediated GIRK responses between GB1aR and GB1bR (Table 1), the GB1aR clone was used in the following experiments as the GABAB1 receptor. To determine which subunit of GABABR, GB1R and/or GB2R is directly coupled to G proteins that transduce signals to the GIRK channels, the carboxy terminus of individual GABABR was fused to G{alpha}i2, the G{alpha} protein that effectively transduces the signal in the GABABR-mediated signaling in the CNS (18, 19), and then injected into the oocytes with its nonfused counterpart. Under these conditions, the signal elicited by the receptor has been reported to be preferentially transmitted through fused G proteins rather than G proteins endogenously expressed in oocytes (13, 20, 31). As a control, the effect of ACh was examined in oocytes expressing the muscarinic M2R fused to G{alpha}i2 (M2R-G{alpha}i2) and GIRK1/2. In agreement with Dascal and colleagues (13, 31), oocytes expressing M2R-G{alpha}i2 and GIRK1/2 showed faster kinetics of activation of ACh-induced inward-rectifying K+ currents as determined by time of 90% of peak (t90%) ACh (10–5 M)-induced GIRK currents compared with oocytes expressing M2R not fused to G{alpha}i2 and GIRK1/2 (Fig. 3). In oocytes coexpressing GB1aR + GB2R-G{alpha}i2 with GIRK1/2, baclofen also elicited faster inward-rectifying K+ currents compared with the oocytes coexpressing GB1aR + GB2R with GIRK1/2 (Fig. 4). These rapid responses to baclofen were not obtained in oocytes coexpressing GBB1aR-G{alpha}i2 + GB2R with GIRK1/2. Coexpression of both fused receptors, GB1aR-G{alpha}i2 + GB2R-G{alpha}i2, did not change the rapid responses to baclofen compared with oocytes expressing GB1aR + GB2R-G{alpha}i2 (Fig. 4).



View larger version (8K):
[in this window]
[in a new window]
 
Fig. 3. ACh-induced GIRK currents in oocytes coexpressing muscarinic M2 receptor (M2R) or M2R fused to G{alpha}i2 protein (M2R-G{alpha}i2) together with GIRK1/2. A: representative trace of ACh-induced GIRK currents in oocytes coexpressing M2R together with GIRK1/2. ACh at 10–5 M was applied as indicated by the horizontal bar for 30 s. B: comparison of kinetics of activation of ACh-induced GIRK currents (IACh) in oocytes coexpressing M2R or M2R-G{alpha}i2 together with GIRK1/2. Representative traces of currents of first 25 s of IACh obtained in the oocytes are shown. Currents were scaled to allow direct comparison of speed of activation as indicated by Ivanina et al. (13). C: summary of measurement of time of 90% of peak (t90%) of IACh. Each bar represents mean ± SE of the t90% from 20 oocytes used in a minimum of 3 independent experiments. *P < 0.05 compared with oocytes coexpressing M2R together with GIRK1/2.

 


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4. Baclofen-induced GIRK currents in oocytes expressing GABAB receptor subunit (GB1aR and GB2R) fused to G{alpha}i2 together with GIRK1/2. Baclofen (10–4 M) was applied for 30 s to the oocytes coexpressing GB1aR + GB2R, GB1aR-G{alpha}i2 + GB2R, GB1aR + GB2R-G{alpha}i2, or GB1aR-G{alpha}i2 + GB2R-G{alpha}i2 together with GIRK1/2. A: comparison of kinetics of activation of baclofen-induced GIRK currents (Ibaclofen) in oocytes coexpressing the combination of GB1aR + GB2R with or without fusing G{alpha}i2 together with GIRK1/2. Representative traces of currents of first 25 s of Ibaclofen obtained in the oocytes are shown. Currents were scaled to allow direct comparison of speed of activation as shown in Fig. 3. B: summary of baclofen-induced currents. Each bar represents mean ± SE of t90% from 20 oocytes in at least 3 independent experiments. *P < 0.05 compared with oocytes coexpressing GB1aR + GB2R together with GIRK1/2; n.s., not significant compared with oocytes coexpressing GB1aR + GB2R together with GIRK1/2.

 
Generation of Ca2+-activated Cl currents in Xenopus oocytes expressing GABABR fused to chimeric G{alpha}qi5 protein. To further assess the direct coupling of GB2R to G proteins, we investigated the effect of baclofen in oocytes coexpressing GB1aR and/or GB2R fused to G{alpha}qi5 protein, a chimeric G{alpha}q protein that enables G{alpha}i/o-coupled receptors to cause PLC-mediated increase in intracellular Ca2+ concentration ([Ca2+]i) via G{alpha}qi5 (6, 9, 15). Baclofen stimulation would be expected to stimulate GABABR to activate PLC through fused G{alpha}qi5 (7, 9, 10). In oocytes coexpressing GB1aR + GB2R-G{alpha}qi5, baclofen (10–4 M) elicited Ca2+-activated Cl currents due to G{alpha}qi5-mediated PLC activation and subsequent increases in [Ca2+]i (Fig. 5A). In contrast, in oocytes expressing GB1aR-G{alpha}qi5 + GB2R, no baclofen-induced Ca2+-activated Cl currents were observed (Fig. 5A). In oocytes expressing GB1aR-G{alpha}qi5 + GB2R-G{alpha}qi5, baclofen (10–4 M) elicited Cl currents in a manner similar to the oocytes coexpressing GB1aR + GB2R-G{alpha}qi5 (Fig. 5A). As a control, ACh (10–5 M) elicited Ca2+-activated Cl currents in oocytes expressing muscarinic M2R fused to G{alpha}qi5 (Fig. 5B), whereas it failed to elicit any currents in oocytes expressing M2R alone as reported previously by our laboratory (15).



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5. Baclofen- or ACh-induced Ca2+-activated Cl currents in oocytes coexpressing GABABR subunits (GB1aR and/or GB2R) fused to G{alpha}qi5 or muscarinic M2R fused to G{alpha}qi5, respectively. A, left: representative trace of baclofen-induced currents in oocytes coexpressing GB1aR + GB2R, GB1aR-G{alpha}qi5 + GB2R, GB1aR + GB2R-G{alpha}qi5, or GB1aR-G{alpha}qi5 + GB2R-G{alpha}qi5. Baclofen (10–4 M) was applied for 30 s to each group of oocytes as indicated by the bars. Right: summary of baclofen-induced Ca2+-activated Cl currents. B, left: representative traces of ACh-induced Ca2+-activated Cl currents in oocytes expressing M2R or M2R-G{alpha}qi5. ACh (10–5 M) was applied for 30 s to each oocyte as indicated by the bars. Right: summary of ACh-induced currents. Each bar represents mean ± SE of the peak currents from independent experiments on at least 6 oocytes. *P < 0.05 compared with GB1aR + GB2R-coexpressing oocytes. **P < 0.05 compared with M2R-expressing oocytes.

 
In BHK cells expressing GB1aR-Cerulean + the triplet tandem of GB2R-Venus-G{alpha}qi5, Cerulean and Venus fluorescence was observed on the cell membranes, similarly to that presented in Fig. 1 (data not shown). There was little difference in FRET efficiency among BHK cells coexpressing GB1aR-Cerulean + GB2R-Venus, GB1aR-Cerulean-G{alpha}qi5 + GB2R-Venus, and GB1aR-Cerulean + GB2R-Venus-G{alpha}qi5 (Table 2), demonstrating that fusion of G{alpha}qi5 did not influence the heterodimer formation of functional GABABR on the cell surface. In addition, there was no difference in peak Ca2+-activated Cl currents between oocytes coexpressing GB1aR + GB2R-G{alpha}qi5 and GB1aR + GB2R-Venus-G{alpha}qi5 (Table 2). In oocytes coexpressing GB1aR-Cerulean-G{alpha}qi5 + GB2R-Venus, a few oocytes responded to baclofen (Table 2), although oocytes coexpressing GB1aR-G{alpha}qi5 + GB2R did not respond to baclofen (Fig. 5A and Table 2).


View this table:
[in this window]
[in a new window]
 
Table 2. Effect of fusion of G{alpha}qi5 protein or fluorescent proteins to GABAB receptor subunits on FRET efficiency and baclofen-induced Ca2+-activated Cl currents

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The present study demonstrated that the functional GABABR formed a heterodimer in living cells and the GB2R subunit of the functional GABABR directly coupled to G proteins to transmit signals to GIRK channels. Analyses by FRET and acceptor bleaching in BHK cells coexpressing GB1aR-Cerulean + GB2R-Venus or GB1bR-Cerulean + GB2R-Venus demonstrated that each receptor combination formed a heterodimer on the cell membrane. The same result was obtained in cells coexpressing combinations of GB1aR-Venus + GB2R-Cerulean. Thus GABAB receptors were morphologically confirmed to form heterodimers with GB1R + GB2R. Furthermore, the GABABR agonists baclofen and 3-APPA elicited inward-rectifying K+ currents in oocytes that coexpressed only GB1R and GB2R together with GIRK1/2, indicating that both GB1R and GB2R are necessary to form functional GABABR, as reported previously by our group (29) and others (10, 24, 26). Our present results also indicated that GB2R was able to associate as a homodimer on the cell surface and that GB1aR also makes a homodimer, but only in the cytoplasm, probably in the endoplasmic reticulum as reported previously (30). We showed that functional GABABR composed of GB1R and GB2R, as well as the GB2R homodimer, were expressed on the cell membrane and the GB1R homodimer was retained in the cytoplasm, although the roles of GB1R and GB2R homodimer complexes remain to be investigated.

GB2R plays key roles in the trafficking of the GB1R subunit to the cell surface (5, 8, 26) and in the mediation of agonist-induced G protein coupling (10, 21). The identity of the GABABR subunit, GB1R and/or GB2R, that is directly coupled to G proteins in the functional GABABR was examined by using each GABABR subunit fused to the G{alpha} protein G{alpha}i2. Gi/o protein-mediated responses in Xenopus oocytes are generally obtained by detecting GIRK currents through activation of endogenously expressed Gi/o proteins in GIRK-expressed oocytes (27, 29, 31). Signals via tandem receptors fused to G protein are thought to be preferentially transmitted through the fused G proteins (31). We demonstrated that oocytes coexpressing muscarinic M2R-G{alpha}i2 together with GIRKs caused faster inward-rectifying K+ currents in response to ACh compared with oocytes coexpressing nonfused M2R with GIRKs. The initial GIRK activation process via tandem muscarinic M2R-G{alpha}i3 is also reported to be faster than that via M2R-mediated activation of G proteins endogenously expressed in oocytes (31). We showed that baclofen elicited faster inward-rectifying K+ currents in oocytes coexpressing GB1aR + GB2R-G{alpha}i2 together with GIRKs compared with oocytes coexpressing GB1aR + nonfused GB2R with GIRKs. This type of rapid response to baclofen was not obtained in oocytes coexpressing GB1aR-G{alpha}i2 + GB2R with GIRKs. These results suggest that G{alpha}i2 fused to GB2R, but not to GB1R, transduced the signal to GIRKs in our experimental system. A recent detailed three-dimensional structure model demonstrated that homo- or heterodimeric signaling molecules of GPCR-G protein were pentamers composed of two of the dimerized receptors with G{alpha}, G{beta}, and G{gamma} subunits (2). On the basis of this model, heterodimeric GABAB receptor-G protein signaling molecules may be composed of two receptors and one trimeric G{alpha}{beta}{gamma} protein presumably associated with GB2R, although further investigation is required.

Further experiments were carried out with GB2R fused to G{alpha}qi5 protein, a chimeric G{alpha}q protein that enables G{alpha}i/o protein-coupled receptors to activate G{alpha}q protein-mediated PLC activation (6, 9, 15). We previously demonstrated (15) that activation of G{alpha}i/o-coupled {delta}-opioid, 5-HT1A, and somatostatin type 2 receptors resulted in increases in [Ca2+]i and subsequent activation of Ca2+-activated Cl currents only when coexpressed with G{alpha}qi5 in Xenopus oocytes. In the present study, we found that baclofen elicited Ca2+-activated Cl currents in oocytes coexpressing GB2R-G{alpha}qi5 + GB1aR but not in those expressing GB1aR-G{alpha}qi5 + GB2R, indicating that baclofen stimulates GABABR and elicits Ca2+-activated Cl currents through only chimeric G{alpha}qi5 fused to GB2R. FRET analysis demonstrated that such constructions of GB2R-G{alpha}qi5 or GB1aR-G{alpha}qi5 did not influence the heterodimeric properties with GB1aR or GB2R on the cell surface, respectively; there was little difference in the FRET efficiency among GB1aR-Cerulean + GB2R-Venus, GB1aR-Cerulean + GB2R-Venus-G{alpha}qi5, and GB1aR-Cerulean-G{alpha}qi5 + GB2R-Venus in BHK cells (Table 2). Similarly, there were no differences in baclofen-elicited Ca2+-activated Cl currents between oocytes coexpressing GB1aR + GB2R-G{alpha}qi5 and GB1aR + GB2R-Venus-G{alpha}qi5 (Table 2), suggesting that insertion of a fluorescent protein between GB2R and G{alpha}qi5 had no effect on GABABR-mediated PLC activation. In a few cases, however, we observed that oocytes coexpressing GABAB1aR-Cerulean-G{alpha}qi5 + GABAB2R-Venus responded to baclofen, although GB1aR-G{alpha}qi5 + GB2R did not (Table 2). This may be a promiscuous coupling of G{alpha}qi5 with a longer carboxy terminus of GB1aR. (Inserted Cerulean between GB1aR and G{alpha}qi5 would create the situation in which the G{alpha}qi5 may access the G protein binding site for GB2R.) Nonetheless, the chimeric G{alpha}qi5 seems to couple selectively to GB2R and activate PLC in the functional GABABR in our experimental system using Xenopus oocytes. These results indicate that the functional GABABR forms a heterodimer with GB1R and GB2R and G proteins that transduce signal to the downstream are coupled to GB2R. Several investigators have shown that intracellular loops 1, 2, and 3 of GB2R are indispensable for the functional coupling of heterodimeric GABABR signaling (7, 10, 11, 14). In addition, they have reported that none of the intracellular loops of GB1R is linked to the functional GABABR-induced signaling (7, 10, 11, 14). Our results are consistent with their conclusions in that only GB2R-linked G proteins are important for the receptor signaling. These findings suggest that intracellular loops of GB1R may not physically couple to G proteins. Because some GABABR-mediated signaling pathways, such as inhibition of voltage-dependent Ca2+ channels, are preferentially mediated via G{alpha}o rather than G{alpha}i in certain cell types (3, 4), other effector signaling systems, including Ca2+ channel inhibition and inhibition and/or activation of adenylate cyclases, should be investigated to further clarify the involvement of dimeric GABABR-induced cellular signaling.

In conclusion, we have demonstrated that functional GABABR forms a heterodimer composed of GB1R and GB2R in living cells and that the G proteins that transduce downstream signals could be coupled to GB2R but not GB1R.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y. Uezono, M. Kanaide, K. Sumikawa, and K. Taniyama), Naito Foundation (to Y. Uezono), and Public Health Research Foundation (to M. Kaibara).


    FOOTNOTES
 

Address for reprint requests and other correspondence: Y. Uezono, Dept. of Pharmacology, Nagasaki Univ. Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan (e-mail: uezonoy{at}alpha.med.nagasaki-u.ac.jp)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
1. Agnati LF, Ferre S, Lluis C, Franco R, and Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55: 509–550, 2003.[Abstract/Free Full Text]

2. Baneres JL and Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J Mol Biol 329: 815–829, 2003.[CrossRef][ISI][Medline]

3. Bettler B, Kaupmann K, Mosbacher J, and Gassmann M. Molecular structure and physiological functions of GABAB receptors. Physiol Rev 84: 835–867, 2004.[Abstract/Free Full Text]

4. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, and Enna SJ. International Union of Pharmacology. XXXIII. Mammalian {gamma}-aminobutyric acidB receptors: structure and function. Pharmacol Rev 54: 247–264, 2002.[Abstract/Free Full Text]

5. Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, and Moss SJ. Intracellular retention of recombinant GABAB receptors. J Biol Chem 273: 26361–26367, 1998.[Abstract/Free Full Text]

6. Coward P, Chan SD, Wada HG, Humphries GM, and Conklin BR. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal Biochem 270: 242–248, 1999.[CrossRef][ISI][Medline]

7. Duthey B, Caudron S, Perroy J, Bettler B, Fagni L, Pin JP, and Prezeau L. A single subunit (GB2) is required for G-protein activation by the heterodimeric GABAB receptor. J Biol Chem 277: 3236–3241, 2002.[Abstract/Free Full Text]

8. Filippov AK, Couve A, Pangalos MN, Walsh FS, Brown DA, and Moss SJ. Heteromeric assembly of GABABR1 and GABABR2 receptor subunits inhibits Ca2+ current in sympathetic neurons. J Neurosci 20: 2867–2874, 2000.[Abstract/Free Full Text]

9. Franek M, Pagano A, Kaupmann K, Bettler B, Pin JP, and Blahos J. The heteromeric GABA-B receptor recognizes G-protein {alpha} subunit C-termini. Neuropharmacology 38: 1657–1666, 1999.[CrossRef][ISI][Medline]

10. Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, Prezeau L, and Pin JP. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function. EMBO J 20: 2152–2159, 2001.[CrossRef][ISI][Medline]

11. Havlickova M, Prezeau L, Duthey B, Bettler B, Pin JP, and Blahos J. The intracellular loops of the GB2 subunit are crucial for G-protein coupling of the heteromeric {gamma}-aminobutyrate B receptor. Mol Pharmacol 62: 343–350, 2002.[Abstract/Free Full Text]

12. Ho BY, Uezono Y, Takada S, Takase I, and Izumi F. Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels. Receptors Channels 6: 363–374, 1999.[ISI][Medline]

13. Ivanina T, Varon D, Peleg S, Rishal I, Porozov Y, Dessauer CW, Keren-Raifman T, and Dascal N. G{alpha}i1 and G{alpha}i3 differentially interact with, and regulate, the G protein-activated K+ channel. J Biol Chem 279: 17260–17268, 2004.[Abstract/Free Full Text]

14. Margeta-Mitrovic M, Jan YN, and Jan LY. Function of GB1 and GB2 subunits in G protein coupling of GABAB receptors. Proc Natl Acad Sci USA 98: 14649–14654, 2001.[Abstract/Free Full Text]

15. Minami K, Uezono Y, Shiraishi M, Okamoto T, Ogata J, Horishita T, Taniyama K, and Shigematsu A. Analysis of the effects of halothane on Gi-coupled muscarinic M2 receptor signaling in Xenopus oocytes using a chimeric G{alpha} protein. Pharmacology 72: 205–212, 2004.[CrossRef][ISI][Medline]

16. Miyawaki A and Tsien RY. Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein. Methods Enzymol 327: 472–500, 2000.[ISI][Medline]

17. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, and Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87–90, 2002.[CrossRef][ISI][Medline]

18. Odagaki Y and Koyama T. Identification of G{alpha} subtype(s) involved in {gamma}-aminobutyric acidB receptor-mediated high-affinity guanosine triphosphatase activity in rat cerebral cortical membranes. Neurosci Lett 297: 137–141, 2001.[CrossRef][ISI][Medline]

19. Odagaki Y, Nishi N, and Koyama T. Functional coupling of GABAB receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramin, and benzalkonium chloride in rat cerebral cortical membranes. J Neural Transm 107: 1101–1116, 2000.[CrossRef][ISI][Medline]

20. Peleg S, Varon D, Ivanina T, Dessauer CW, and Dascal N. G{alpha}i controls the gating of the G protein-activated K+ channel, GIRK. Neuron 33: 87–99, 2002.[CrossRef][ISI][Medline]

21. Restituito S, Couve A, Bawagan H, Jourdain S, Pangalos MN, Calver AR, Freeman KB, and Moss SJ. Multiple motifs regulate the trafficking of GABAB receptors at distinct checkpoints within the secretory pathway. Mol Cell Neurosci 28: 747–756, 2005.[CrossRef][ISI][Medline]

22. Riven I, Kalmanzon E, Segev L, and Reuveny E. Conformational rearrangements associated with the gating of the G protein-coupled potassium channel revealed by FRET microscopy. Neuron 38: 225–235, 2003.[CrossRef][ISI][Medline]

23. Rizzo MA, Springer GH, Granada B, and Piston DW. An improved cyan fluorescent protein variant useful for FRET. Nat Biotechnol 22: 445–449, 2004.[CrossRef][ISI][Medline]

24. Robbins MJ, Calver AR, Filippov AK, Hirst WD, Russell RB, Wood MD, Nasir S, Couve A, Brown DA, Moss SJ, and Pangalos MN. GABAB2 is essential for G-protein coupling of the GABAB receptor heterodimer. J Neurosci 21: 8043–8052, 2001.[Abstract/Free Full Text]

25. Stanasila L, Perez JB, Vogel H, and Cotecchia S. Oligomerization of the {alpha}1a- and {alpha}1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 276: 40239–40251, 2003.

26. Thuault SJ, Brown JT, Sheardown SA, Jourdain S, Fairfax B, Spencer JP, Restituito S, Nation JH, Topps S, Medhurst AD, Randall AD, Couve A, Moss SJ, Collingridge GL, Pangalos MN, Davies CH, and Calver AR. The GABAB2 subunit is critical for the trafficking and function of native GABAB receptors. Biochem Pharmacol 68: 1655–1666, 2004.[CrossRef][ISI][Medline]

27. Uezono Y, Akihara M, Kaibara M, Kawano C, Shibuya I, Ueda Y, Yanagihara N, Toyohira Y, Yamashita H, Taniyama K, and Izumi F. Activation of inwardly rectifying K+ channels by GABA-B receptors expressed in Xenopus oocytes. Neuroreport 9: 583–587, 1998.[ISI][Medline]

28. Uezono Y, Bradley J, Min C, McCarty NA, Quick M, Riordan JR, Chavkin C, Zinn K, Lester HA, and Davidson N. Receptors that couple to 2 classes of G proteins increase cAMP and activate CFTR expressed in Xenopus oocytes. Receptors Channels 1: 233–241, 1993.[ISI][Medline]

29. Uezono Y, Kaibara M, Murasaki O, and Taniyama K. Involvement of G protein {beta}{gamma}-subunits in diverse signaling induced by Gi/o-coupled receptors: study using the Xenopus oocyte expression system. Am J Physiol Cell Physiol 287: C885–C894, 2004.[Abstract/Free Full Text]

30. Villemure JF, Adam L, Bevan NJ, Gearing K, Chenier S, and Bouvier M. Subcellular distribution of GABAB receptor homo- and hetero-dimers. Biochem J 388: 47–55, 2005.[CrossRef][ISI][Medline]

31. Vorobiov D, Bera AK, Keren-Raifman T, Barzilai R, and Dascal N. Coupling of the muscarinic m2 receptor to G protein-activated K+ channels via G{alpha}z and a receptor-G{alpha}z fusion protein. Fusion between the receptor and G{alpha}z eliminates catalytic (collision) coupling. J Biol Chem 275: 4166–4170, 2000.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Physiol.Home page
C. E. Fowler, P. Aryal, K. F. Suen, and P. A. Slesinger
Evidence for association of GABAB receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins
J. Physiol., April 1, 2007; 580(1): 51 - 65.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/C200    most recent
00269.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uezono, Y.
Right arrow Articles by Taniyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uezono, Y.
Right arrow Articles by Taniyama, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.